Neurosense Therapeutics Ltd.’s (NRSN) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Neurosense Therapeutics Ltd. is a Buy.

Neurosense Therapeutics Ltd.’s (NRSN) 20-Day exponential moving average is 1.76, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.74, making it a Sell.

Neurosense Therapeutics Ltd.’s (NRSN) 50-Day exponential moving average is 1.56, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.74, making it a Buy.

Advanced Chart >

Neurosense Therapeutics Ltd. (NRSN) Pivot Points

Apr 19, 2024, 02:32 PM

Classic

0.64

1.07

1.38

1.82

2.13

2.56

2.88

Fibonacci

1.07

1.35

1.53

1.82

2.10

2.28

2.56

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurosense Therapeutics Ltd. (NRSN) Moving Averages

Apr 19, 2024, 02:32 PM

MA5

1.88Sell

1.82Sell

MA10

1.83Sell

1.81Sell

MA20

1.70Buy

1.76Sell

MA50

1.56Buy

MA100

1.19Buy

1.35Buy

MA200

1.06Buy

1.30Buy

Neurosense Therapeutics Ltd.’s (NRSN) 10-Day exponential moving average is 1.81, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.74, making it a Sell.

Neurosense Therapeutics Ltd.’s (NRSN) 100-Day exponential moving average is 1.35, while Neurosense Therapeutics Ltd.’s (NRSN) share price is $1.74, making it a Buy.

Neurosense Therapeutics Ltd.’s (NRSN) stock price is $1.74 and Neurosense Therapeutics Ltd.’s (NRSN) 50-day simple moving average is 1.56, creating a Buy signal.

Neurosense Therapeutics Ltd.’s (NRSN) stock price is $1.74 and Neurosense Therapeutics Ltd.’s (NRSN) 100-day simple moving average is 1.19, creating a Buy signal.

Neurosense Therapeutics Ltd.’s (NRSN) stock price is $1.74 and Neurosense Therapeutics Ltd.’s (NRSN) 200-day simple moving average is 1.06, creating a Buy signal.

Neurosense Therapeutics Ltd. (NRSN) Technical Indicators

Apr 19, 2024, 02:32 PM

RSI (14)

51.10

Neutral

STOCH (9,6)

47.92

Neutral

STOCHRSI (14)

53.55

Neutral

MACD (12,26)

0.08

Buy

ADX (14)

15.79

Buy

Williams %R

-60.00

Buy

CCI (14)

15.90

Neutral

ATR (14)

0.23

Ultimate Oscillator

49.72

Neutral

ROC

24.29

Buy

Neurosense Therapeutics Ltd.’s (NRSN) Relative Strength Index (RSI) is 51.10, creating a Neutral signal.

Neurosense Therapeutics Ltd.’s (NRSN) Trend Strength Indicator (ADX) is 15.79, creating a Buy signal.

Neurosense Therapeutics Ltd.’s (NRSN) Commodity Channel Index (CCI) is 15.90, creating a Neutral signal.

Neurosense Therapeutics Ltd.’s (NRSN) Price Rate of Change (ROC) is 24.29, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NRSN a Buy, Hold, or Sell?

Based on NRSN’s technical indicators, NRSN is a Buy.

What is NRSN’s RSI (14)?

NRSN’s RSI (14) is 51.10, which suggests NRSN is a Neutral.

What is NRSN’s MACD?

NRSN’s MACD is 0.08, which suggests NRSN is a Buy.

What is NRSN’s 5-day moving average?

NRSN’s 5-day moving average is 1.88, which suggests NRSN is a Sell.

What is NRSN’s 20-day moving average?

NRSN 20-day moving average is 1.70, which suggests NRSN is a Buy.

What is NRSN’s 50-day moving average?

NRSN’s 50-day moving average is 1.56, which suggests NRSN is a Buy.

What is NRSN’s 200-day moving average?

NRSN’s 200-day moving average is 1.06, which suggests NRSN is a Buy.

What is NRSN’s Williams % R (14)?

NRSN’s Williams % R (14) is -60.00, which suggests NRSN is a Buy.

What is NRSN’s CCI (14)?

NRSN’s CCI (14) is 15.90, which suggests NRSN is a Neutral.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing